Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence.

Clin Drug Investig · 2023 · PMC10514156 · PMID 37479867

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although there was a favorable trend toward improved survival outcomes in the TCHP group, differences in EFS between AC and non-AC groups were not statistically different.

also in 466 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.